Free Trial

Charles Zhou Analyst Performance

Analyst at Guggenheim

Charles Zhou is a stock analyst at Guggenheim across a range of sectors, covering 2 publicly traded companies. Over the past year, Charles Zhou has issued 2 stock ratings, including and buy recommendations. While full access to Charles Zhou's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Charles Zhou's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
2 Last 0 Years
Buy Recommendations
100.00% 2 Buy Ratings
Companies Covered
2 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%2 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
2 companies

Charles Zhou, an analyst at Guggenheim, currently covers 2 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
1 company
50.0%
Business Services
1 company
50.0%

Charles Zhou of Guggenheim specializes in stock coverage within the Medical sector, with additional focus on Business Services companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
1 company
50.0%
TECHNOLOGY SERVICES
1 company
50.0%

Charles Zhou's Ratings History at Guggenheim

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
8/25/2025Boost Price Target$12.12$20.00Buy
Futu Holdings Limited Sponsored ADR stock logo
FUTU
Futu
3/17/2025Boost Price Target$117.75$136.00Buy